...
首页> 外文期刊>Clinical ophthalmology >The effect of posterior sub-Tenon’s capsule triamcinolone acetonide injection to that of pars plana vitrectomy for diabetic macular edema
【24h】

The effect of posterior sub-Tenon’s capsule triamcinolone acetonide injection to that of pars plana vitrectomy for diabetic macular edema

机译:后胎胶囊粒细胞酮酮肽注射对糖尿病性黄斑水肿的Pars Plana Vitrecomy的影响

获取原文
           

摘要

Purpose: To compare the effect of posterior sub-Tenon’s capsule triamcinolone acetonide (STTA) injection to that of pars plana vitrectomy (PPV) for diabetic macular edema (DME).Patients and methods: The medical records of 50 patients (52 eyes) with DME were reviewed. Twenty-six eyes underwent STTA (20 mg) and the other 26 eyes underwent vitrectomy combined with cataract surgery. The central macular thickness (CMT), measured by optical coherence tomography, and best-corrected visual acuity (BCVA) were determined before and 1, 3, and 6 months after treatment.Results: The differences in the BCVA and the CMT between the STTA group and the PPV group were not significant before or at any time after the treatment. In both the STTA and PPV groups, there were significant differences between the pre-treatment CMT and BCVA at any time after treatment.Conclusion: We recommend STTA injection for the treatment of DME.
机译:目的:将后胎胶囊粒细胞酮(STTA)注射液(STTA)注射对糖尿病性玻璃体水肿(DME)的疗法(DME)的效果进行比较。患者和方法:50例患者的病历(52只眼)审查了DME。二十六只眼睛接受了STTA(20毫克),另外26只眼睛接受了玻璃体切除术与白内障手术相结合。通过光学相干断层扫描测量的中央黄斑厚度(CMT)和最佳校正的视力(BCVA)在治疗后1,3和6个月内测定。结果:BCVA和STTA之间的CMT的差异群体和PPV组在治疗后的任何时候都不重要。在STTA和PPV组中,在治疗后的任何时间在治疗预处理CMT和BCVA之间存在显着差异。结论:我们建议STTA注射用于治疗DME。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号